Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A with needle-free injector (MEDJET) in palmar hyperhidrosis
jRCTs041180067Completed
- Sponsor
- Metsera
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in Primary hyperhidrosis (PH) (2 arms), sponsored by Metsera. Primary endpoint: Pain level on each palm right after injections. Started Mar 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on jRCTs041180067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180067.